In eight days, an artificial intelligence company most people had never heard of became a household name.

17.9 million people worldwide are living with rheumatoid arthritis. The clinical assumption underlying there treatment plans is about to break. CAR-T cell therapy could offer drug-free remission.

The conventional narrative says frontier technology requires massive capital. These women are proving the opposite: capital efficiency isn’t about doing less with less—it’s about achieving breakthrough outcomes through architecture that compounds rather than burns resources.

Intel Loihi 3 and IBM NorthPole achieve 1,000x GPU efficiency. The neuromorphic revolution just ended NVIDIA’s edge AI monopoly—and the strategic implications cascade across robotics, autonomous vehicles, and distributed intelligence deployment.